Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Clinical results of active surveillance for extra-abdominal desmoid-type fibromatosis.

Cancer medicine - 1 Mar 2023

Sakai Tomohisa, Nishida Yoshihiro, Ito Kan, Ikuta Kunihiro, Urakawa Hiroshi, Koike Hiroshi, Imagama Shiro

Abstract excerpt

BACKGROUND: The treatment of choice for desmoid-type fibromatosis (DF) has been changed to active surveillance (AS). However, few studies have reported clinical outcomes of AS modality in Asian countries. This study aimed to clarify the significance of AS as a DF treatment modality. METHODS: A total of 168 lesions from 162 patients with extra-abdominal DF were included. The mean age at diagnosis was 39 years...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Desmoid Tumors
Share to CTNNB1 gene
Share to Mutation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Risk Factors

Share to Treatment Outcome

Source

Open in PubMed Open full text

Identifiers

PMID: 36210645
DOI: 10.1002/cam4.5329
PMCID: PMC10028109

Genes

CTNNB1

Variants

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Clinical results of active surveillance for extra-abdominal desmoid-type fibromatosis.PMID 36210645Read ↗

Trends in diagnostic and therapeutic strategies for extra-abdominal desmoid-type fibromatosis: Japanese musculoskeletal oncology group questionnaire survey.Semantic proximity Read ↗

A Nationwide Prospective Clinical Trial on Active Surveillance in Patients With Non-intraabdominal Desmoid-type Fibromatosis: The GRAFITI Trial.Semantic proximity Read ↗

Desmoid-Type Fibromatosis: Who, When, and How to Treat.Semantic proximity Read ↗

The Evolving Management of Desmoid Fibromatosis.Semantic proximity Read ↗

Evaluation of diagnostic algorithm and therapeutic interventions for intra-abdominal desmoid tumors.Semantic proximity Read ↗

Desmoid fibromatosis: is the current picture changing?Semantic proximity Read ↗

Extra-abdominal desmoid fibromatosis: A review of management, current guidance and unanswered questions.Semantic proximity Read ↗

Characteristics and outcome of intra-abdominal desmoid-type fibromatosis.Semantic proximity Read ↗

Optimal therapy for desmoid tumors: current options and challenges for the future.Semantic proximity Read ↗

Biology and Treatment of Aggressive Fibromatosis or Desmoid Tumor.Semantic proximity Read ↗

Long-term Outcomes of Oral Vinorelbine in Advanced, Progressive Desmoid Fibromatosis and Influence of CTNNB1 Mutational Status.Semantic proximity Read ↗

A rare and interesting case of desmoid-type fibromatosis arising from the fat layer of the abdominal wall: A case reportSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.